pamidronate has been researched along with Pregnancy in 20 studies
Pregnancy: The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.
| Excerpt | Relevance | Reference |
|---|---|---|
| " When conventional treatment of hypercalcemia failed, pamidronate dramatically decreased both the calcium levels and the frequency of uterine contractions." | 7.73 | Malignant hypercalcemia in pregnancy: effect of pamidronate on uterine contractions. ( Culbert, EC; Schfirin, BS, 2006) |
| "It could be posited that pamidronate exerted a positive protective effect on the mother's skeleton with no evidence of adverse effects on pregnancy or on the baby's health to date." | 3.76 | Intravenous bisphosphonate treatment and pregnancy: its effects on mother and infant bone health. ( Mastaglia, SR; Oliveri, B; Watman, NP, 2010) |
| " When conventional treatment of hypercalcemia failed, pamidronate dramatically decreased both the calcium levels and the frequency of uterine contractions." | 3.73 | Malignant hypercalcemia in pregnancy: effect of pamidronate on uterine contractions. ( Culbert, EC; Schfirin, BS, 2006) |
| "The pregnancies of two women with osteogenesis imperfecta who received intravenous pamidronate before conception are reported." | 3.72 | Maternal and fetal outcome after long-term pamidronate treatment before conception: a report of two cases. ( Glorieux, FH; Munns, CF; Rauch, F; Ward, L, 2004) |
| "Uterine leiomyomas are the most common pelvic tumor, and a frequent indication of the need for gynecologic surgery." | 1.37 | Severe hypercalcemia associated with uterine leiomyoma in pregnancy. ( Richardson, M; Spruill, L; Sullivan, S; Tarnawa, E; Underwood, P, 2011) |
| "Transient osteoporosis is a rare condition causing regional pain, immobility and functional compromise." | 1.36 | Transient osteoporosis associated with pregnancy: use of bisphosphonate in treating a lactating mother. ( Jawad, AS; Shaikh, MF; Shenker, NG, 2010) |
| "A strategy that blocks localized bone resorption may prevent the progression of the disease." | 1.31 | Inhibition of cholesteatomatous bone resorption with pamidronate disodium. ( Chung, JW; Kim, HJ; Lee, SH; Park, MH; Yoon, TH, 2001) |
| "Pamidronate was the only agent tested which suppressed the increase in bone resorption associated with macrophage exposure to bone cement particles to levels which were not significantly different from unexposed calvaria." | 1.29 | Pharmacologic inhibition of particulate-induced bone resorption. ( Algan, SA; Horowitz, SM; Purdon, MA, 1996) |
| " However, with both modes of administration, it was evident that after equivalent dosing peroral and parenteral studies yielded similar results." | 1.28 | Reproduction toxicity studies with pamidronate. ( Bentley, P; Fritz, H; Graepel, P; Miyamoto, M; Slater, SR, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.00) | 18.7374 |
| 1990's | 6 (30.00) | 18.2507 |
| 2000's | 5 (25.00) | 29.6817 |
| 2010's | 8 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rigg, J | 1 |
| Gilbertson, E | 1 |
| Barrett, HL | 1 |
| Britten, FL | 1 |
| Lust, K | 1 |
| Olvera, D | 1 |
| Stolzenfeld, R | 1 |
| Fisher, E | 1 |
| Nolan, B | 1 |
| Caird, MS | 1 |
| Kozloff, KM | 1 |
| Mastaglia, SR | 1 |
| Watman, NP | 1 |
| Oliveri, B | 1 |
| Tarnawa, E | 1 |
| Sullivan, S | 1 |
| Underwood, P | 1 |
| Richardson, M | 1 |
| Spruill, L | 1 |
| Vujasinovic-Stupar, N | 1 |
| Pejnovic, N | 1 |
| Markovic, L | 1 |
| Zlatanovic, M | 1 |
| Rozenbaum, M | 1 |
| Boulman, N | 1 |
| Rimar, D | 1 |
| Kaly, L | 1 |
| Rosner, I | 1 |
| Slobodin, G | 1 |
| Chen, CP | 1 |
| Lin, SP | 1 |
| Su, YN | 1 |
| Huang, JP | 1 |
| Chern, SR | 1 |
| Su, JW | 1 |
| Wang, W | 1 |
| Shenker, NG | 1 |
| Shaikh, MF | 1 |
| Jawad, AS | 1 |
| Munns, CF | 1 |
| Rauch, F | 1 |
| Ward, L | 1 |
| Glorieux, FH | 1 |
| Culbert, EC | 1 |
| Schfirin, BS | 1 |
| Cairo, C | 1 |
| Mancino, G | 1 |
| Cappelli, G | 1 |
| Pauza, CD | 1 |
| Galli, E | 1 |
| Brunetti, E | 1 |
| Colizzi, V | 1 |
| Horowitz, SM | 2 |
| Algan, SA | 1 |
| Purdon, MA | 1 |
| Illidge, TM | 1 |
| Hussey, M | 1 |
| Godden, CW | 1 |
| Van Beek, E | 1 |
| Löwik, C | 1 |
| Que, I | 1 |
| Papapoulos, S | 1 |
| Gonzales, JB | 1 |
| Siminoski, K | 1 |
| Fitzgerald, AA | 1 |
| Flesch, G | 1 |
| Gross, MS | 1 |
| Yoon, TH | 1 |
| Lee, SH | 1 |
| Park, MH | 1 |
| Chung, JW | 1 |
| Kim, HJ | 1 |
| Graepel, P | 1 |
| Bentley, P | 1 |
| Fritz, H | 1 |
| Miyamoto, M | 1 |
| Slater, SR | 1 |
| van der Pluijm, G | 1 |
| Löwik, CW | 2 |
| de Groot, H | 1 |
| Alblas, MJ | 1 |
| van der Wee-Pals, LJ | 1 |
| Bijvoet, OL | 2 |
| Papapoulos, SE | 1 |
| Boonekamp, PM | 1 |
| van de Pluym, G | 1 |
| van de Wee-Pals, L | 1 |
| Bloys van Treslong-de Groot, H | 1 |
20 other studies available for pamidronate and Pregnancy
| Article | Year |
|---|---|
Primary Hyperparathyroidism in Pregnancy: Maternofetal Outcomes at a Quaternary Referral Obstetric Hospital, 2000 Through 2015.
Topics: Adult; Antihypertensive Agents; Calcium; Female; Humans; Hyperparathyroidism, Primary; Infant, Newbo | 2019 |
Pamidronate Administration During Pregnancy and Lactation Induces Temporal Preservation of Maternal Bone Mass in a Mouse Model of Osteogenesis Imperfecta.
Topics: Animals; Bone Density; Disease Models, Animal; Female; Humans; Lactation; Mice; Osteogenesis; Osteog | 2019 |
Intravenous bisphosphonate treatment and pregnancy: its effects on mother and infant bone health.
Topics: Bone Density; Bone Density Conservation Agents; Diphosphonates; Female; Follow-Up Studies; Gaucher D | 2010 |
Severe hypercalcemia associated with uterine leiomyoma in pregnancy.
Topics: Adult; Calcitriol; Calcium; Critical Care; Diphosphonates; Female; Gynecologic Surgical Procedures; | 2011 |
Pregnancy-associated spinal osteoporosis treated with bisphosphonates: long-term follow-up of maternal and infants outcome.
Topics: Adult; Back Pain; Bone Density; Bone Density Conservation Agents; Child; Diphosphonates; Etidronic A | 2012 |
Uncommon transient osteoporosis of pregnancy at multiple sites associated with cytomegalovirus infection: is there a link?
Topics: Absorptiometry, Photon; Adult; Alendronate; Ankle Joint; Bone Density Conservation Agents; Cytomegal | 2011 |
Uncomplicated vaginal delivery in two consecutive pregnancies carried to term in a woman with osteogenesis imperfecta type I and bisphosphonate treatment before conception.
Topics: Adult; Bone Density Conservation Agents; Delivery, Obstetric; Diphosphonates; Female; Humans; Infant | 2012 |
Transient osteoporosis associated with pregnancy: use of bisphosphonate in treating a lactating mother.
Topics: Adult; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Lactation; Osteoporosis; Pa | 2010 |
Maternal and fetal outcome after long-term pamidronate treatment before conception: a report of two cases.
Topics: Adult; Anti-Inflammatory Agents; Clubfoot; Diphosphonates; Female; Humans; Hypocalcemia; Infant; Inj | 2004 |
Malignant hypercalcemia in pregnancy: effect of pamidronate on uterine contractions.
Topics: Adult; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Breech Presentation; Cesarean Sectio | 2006 |
Vdelta2 T-lymphocyte responses in cord blood samples from Italy and Côte d'Ivoire.
Topics: Antigens, Bacterial; Cell Differentiation; Cell Proliferation; Cells, Cultured; Cote d'Ivoire; Dipho | 2008 |
Pharmacologic inhibition of particulate-induced bone resorption.
Topics: Analysis of Variance; Animals; Animals, Newborn; Bone Cements; Bone Resorption; Calcitonin; Calcium; | 1996 |
Malignant hypercalcaemia in pregnancy and antenatal administration of intravenous pamidronate.
Topics: Adult; Breast Neoplasms; Diphosphonates; Fatal Outcome; Female; Humans; Hypercalcemia; Infant, Newbo | 1996 |
Dissociation of binding and antiresorptive properties of hydroxybisphosphonates by substitution of the hydroxyl with an amino group.
Topics: Amines; Analysis of Variance; Animals; Binding Sites; Bone Matrix; Bone Resorption; Calcium Oxalate; | 1996 |
Effects of polyethylene on macrophages.
Topics: Animals; Bone Resorption; Calcium Radioisotopes; Cells, Cultured; Culture Media, Conditioned; Dinopr | 1997 |
Intravenous pamidronate for treatment of reflex sympathetic dystrophy during breast feeding.
Topics: Absorptiometry, Photon; Adult; Animals; Bone Density; Breast Feeding; Diphosphonates; Female; Humans | 2000 |
Inhibition of cholesteatomatous bone resorption with pamidronate disodium.
Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents; Bone Resorption; Calcium; Cholesteatoma, Middle | 2001 |
Reproduction toxicity studies with pamidronate.
Topics: Administration, Oral; Animals; Bone and Bones; Calcium; Diphosphonates; Embryo, Mammalian; Female; F | 1992 |
Modulation of PTH-stimulated osteoclastic resorption by bisphosphonates in fetal mouse bone explants.
Topics: Animals; Bone Resorption; Calcium; Clodronic Acid; Culture Techniques; Diphosphonates; Dose-Response | 1991 |
Bisphosphonates can reduce osteoclastic bone resorption by two different mechanisms.
Topics: Animals; Bone and Bones; Bone Resorption; Cell Differentiation; Chemotaxis; Clodronic Acid; Culture | 1986 |